Analyzing factors determining vaccination willingness against COVID-19 in Germany 2020.
COVID-19
Complementary alternative medicine
Conspiracy belief
Educational level
Predictors of vaccination
Social influence
Willingness to be vaccinated
Journal
Vaccine: X
ISSN: 2590-1362
Titre abrégé: Vaccine X
Pays: England
ID NLM: 101748769
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
27
07
2022
revised:
28
06
2023
accepted:
29
06
2023
medline:
14
8
2023
pubmed:
14
8
2023
entrez:
14
8
2023
Statut:
epublish
Résumé
The study is based on a German single-topic population survey on vaccination willingness against COVID-19 (VWC) by the authors (2020, n = 2014). The single-topic survey allowed us to test several competing explanations for VWC, as discussed in the literature. The VWC in the sample was 67.3%. Logistic regression was used to identify factors affecting VWC. Being at high risk from COVID-19 and having received flu vaccination have a positive impact on VWC. Perceived VWC of friends has a strong positive effect on respondents' VWC. Bivariate relationships of gender, age, and level of education with VWC were no longer significant in a multivariate analysis. Trust in alternative medicine and belief in conspiracy theories have a negative effect on VWC.
Identifiants
pubmed: 37577261
doi: 10.1016/j.jvacx.2023.100342
pii: S2590-1362(23)00083-9
pmc: PMC10422663
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100342Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The project is funded by the Bavarian State Ministry of Science and the Arts as part of the Regensburg Center of Health Sciences and Technology (RCHST) at the Ostbayerische Technische Hochschule Regensburg (OTH Regensburg). Open Access publication is funded by OTH Regensburg. The sponsor was not involved in data collection, data analysis nor in any stage of the submission process.
Références
Gesundheitswesen. 2021 Oct;83(10):789-796
pubmed: 34348412
Soc Sci Med. 2021 Mar;272:113688
pubmed: 33485215
Prev Med. 2021 Sep;150:106694
pubmed: 34171345
PLoS One. 2018 Dec 7;13(12):e0208601
pubmed: 30532274
Papillomavirus Res. 2016 Dec;2:167-172
pubmed: 29074176
N Engl J Med. 2001 Feb 1;344(5):375-9
pubmed: 11172172
Soc Sci Med. 2020 Jun;255:113019
pubmed: 32408085
Vaccines (Basel). 2021 Sep 24;9(10):
pubmed: 34696179
Public Health. 2021 May;194:245-251
pubmed: 33965796
Nature. 2021 Mar;591(7851):520-522
pubmed: 33737753
BMC Infect Dis. 2010 Apr 19;10:99
pubmed: 20403201
Vaccines (Basel). 2022 Nov 22;10(12):
pubmed: 36560390
Vaccine. 2021 Apr 8;39(15):2024-2034
pubmed: 33722411
JAMA. 2021 Jan 12;325(2):125-126
pubmed: 33315079
Soc Sci Med. 2020 Nov;265:113414
pubmed: 33038683
Front Public Health. 2020 Jul 14;8:381
pubmed: 32760691
Nat Rev Immunol. 2022 Jun;22(6):333-334
pubmed: 35440758
Curr Opin Psychol. 2022 Aug;46:101346
pubmed: 35486966
Soc Sci Med. 2021 Mar;272:113638
pubmed: 33414032
Immunity. 2020 May 19;52(5):737-741
pubmed: 32433946
Gesundheitswesen. 2003 Jul;65(7):464-70
pubmed: 12891479
Soc Sci Med. 2022 May;301:114912
pubmed: 35354105
PLoS One. 2021 May 10;16(5):e0248372
pubmed: 33970933
Vaccine. 2011 Oct 6;29(43):7364-9
pubmed: 21807048
Nature. 2020 Dec;588(7837):315-320
pubmed: 32846427
Pathog Glob Health. 2022 Jun;116(4):236-243
pubmed: 34928187
Eur J Health Econ. 2020 Sep;21(7):977-982
pubmed: 32591957
PLoS One. 2017 Jan 26;12(1):e0170550
pubmed: 28125629
Gesundheitswesen. 2020 Sep;82(8-09):670-675
pubmed: 32858757